Firebrick Pharma Limited (ASX: FRE)
Australia
· Delayed Price · Currency is AUD 0.0560
+0.0020 (3.70%)
Dec 20, 2024, 3:45 PM AEST
Firebrick Pharma Revenue
In the fiscal year ending June 30, 2024, Firebrick Pharma had annual revenue of 2.75M AUD with 12,096.48% growth. Firebrick Pharma had revenue of 934.18K in the half year ending June 30, 2024, a decrease of -13.49%.
Revenue
2.75M
Revenue Growth
+12,096.48%
P/S Ratio
3.65
Revenue / Employee
n/a
Employees
n/a
Market Cap
11.77M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 2.75M | 2.73M | 12,096.48% |
| Jun 30, 2023 | 22.55K | -1.06M | -97.92% |
| Jun 30, 2022 | 1.08M | 661.35K | 156.72% |
| Jun 30, 2021 | 422.00K | -86.98K | -17.09% |
| Jun 30, 2020 | 508.98K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 22.18B |
| ResMed Inc. | 6.93B |
| Pro Medicus Limited | 161.50M |
| Fisher & Paykel Healthcare Corporation Limited | 1.74B |
| Cochlear Limited | 2.24B |
| Sonic Healthcare Limited | 8.97B |
| Telix Pharmaceuticals Limited | 645.68M |
| Ramsay Health Care Limited | 16.66B |